CGT windfall for company execs

Company directors and other senior executives are set for significant refunds from the Inland Revenue, following its decision not to contest a ruling in the Court of Appeal.

Written by Larry Schlesinger

The case in question, Mansworth vs Jelly, allows members of unapproved share options schemes and enterprise management incentive plans to reduce their tax paid on capital gains made since April 2000.

Under the new ruling, the acquisition cost of shares is deemed to be their market value at the time the option is exercised, which may reduce the value of a capital gain or turn it into a loss.

Advertisement

Unapproved share options schemes have been one of the most popular ways to reward company directors, most notably, outgoing Vodafone chief Sir Christopher Gent, who holds 61 million shares.

Experts expect that the relief will not last long, as it offsets CGT reform put in place by Gordon Brown in his last Budget - this set a tax limit of 10% on shares that were not exercised for a period of two years.

The ruling will not benefit employees who acquired shares through approved Save As You Earn (SAYE) schemes and approved Company Share Option Plans (CSOPs). Here the acquisition cost is the exercise price paid for the shares.

Tags:

Comments

White papers

Related jobs

More Accounting jobs

Spotlight

Ted Bell, Abel and Cole FD

Profile: Ted Bell, FD of Abel and Cole

The combination of the online shopping boom and a hunger...

Top 30 Accounting Networks and Associations 2008

The race to become the biggest firm on the planet...

Barack Obama Accountancy Age cover October 2008

Obama: asset or liability?

What an Obama presidency could mean for you

Find your next job

Find your next job
Salary Checker

Job of the week

More finance jobs

Newsletters

Sign up here for the very latest news delivered to your inbox. Choose from the following options:

Your next job

Have your say

Will proposed tax cuts help to stimulate the economy?
Yes
No

Advertisement

Search white papers

Search white papers

Advertisement